Arcturus Therapeutics Holdings Inc will transfer mRNA vaccine technology to Vingroup this month to start a clinical trial of its Covid-19 vaccine candidate.
Arcturus Therapeutics Holdings Inc will transfer mRNA vaccine technology to Vingroup this month to start a clinical trial of its Covid-19 vaccine candidate.